Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh
Tweet
Share
E-mailGet Alerts QNRX Hot Sheet
Join SI Premium – FREE
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.
For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
